Bausch Health Co. Inc. (BHC) Misses Q1 EPS, Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Bausch Health Companies Inc. Announces First-Quarter 2022 Results
May 10, 2022 6:59 AM EDTFirst-Quarter 2022 Financial ResultsRevenues of $1.918 BillionGAAP Net Loss of $69 MillionAdjusted EBITDA (non-GAAP)1Â of $732 Million Bausch + Lomb Commences Trading Under "BLCO" Ticker Following IPO2Updates Full-Year Revenue and Adjusted EBITDA (non-GAAP)1 Guidance Ranges
LAVAL, QC, May 10, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company" or "we") today announced its first-quarter 2022 financial results.
"Our organic3Â growth in the first quarter of 2022 was stable compared to the same quarter... More
